| UniProt ID | SOX10_HUMAN | |
|---|---|---|
| UniProt AC | P56693 | |
| Protein Name | Transcription factor SOX-10 | |
| Gene Name | SOX10 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 466 | |
| Subcellular Localization |
Cytoplasm . Nucleus . Mitochondrion outer membrane Peripheral membrane protein Cytoplasmic side . |
|
| Protein Description | Transcription factor that plays a central role in developing and mature glia. Specifically activates expression of myelin genes, during oligodendrocyte (OL) maturation, such as DUSP15 and MYRF, thereby playing a central role in oligodendrocyte maturation and CNS myelination. Once induced, MYRF cooperates with SOX10 to implement the myelination program. Transcriptional activator of MITF, acting synergistically with PAX3. [PubMed: 21965087] | |
| Protein Sequence | MAEEQDLSEVELSPVGSEEPRCLSPGSAPSLGPDGGGGGSGLRASPGPGELGKVKKEQQDGEADDDKFPVCIREAVSQVLSGYDWTLVPMPVRVNGASKSKPHVKRPMNAFMVWAQAARRKLADQYPHLHNAELSKTLGKLWRLLNESDKRPFIEEAERLRMQHKKDHPDYKYQPRRRKNGKAAQGEAECPGGEAEQGGTAAIQAHYKSAHLDHRHPGEGSPMSDGNPEHPSGQSHGPPTPPTTPKTELQSGKADPKRDGRSMGEGGKPHIDFGNVDIGEISHEVMSNMETFDVAELDQYLPPNGHPGHVSSYSAAGYGLGSALAVASGHSAWISKPPGVALPTVSPPGVDAKAQVKTETAGPQGPPHYTDQPSTSQIAYTSLSLPHYGSAFPSISRPQFDYSDHQPSGPYYGHSGQASGLYSAFSYMGPSQRPLYTAISDPSPSGPQSHSPTHWEQPVYTTLSRP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MAEEQDLSEVELSPV CCCCCCCCCCCCCCC | 48.13 | 29255136 | |
| 13 | Phosphorylation | DLSEVELSPVGSEEP CCCCCCCCCCCCCCC | 12.20 | 29255136 | |
| 17 | Phosphorylation | VELSPVGSEEPRCLS CCCCCCCCCCCCCCC | 38.73 | 29255136 | |
| 24 | Phosphorylation | SEEPRCLSPGSAPSL CCCCCCCCCCCCCCC | 30.73 | 29255136 | |
| 27 | Phosphorylation | PRCLSPGSAPSLGPD CCCCCCCCCCCCCCC | 40.15 | 29255136 | |
| 30 | Phosphorylation | LSPGSAPSLGPDGGG CCCCCCCCCCCCCCC | 45.75 | 29255136 | |
| 40 | Phosphorylation | PDGGGGGSGLRASPG CCCCCCCCCCCCCCC | 37.62 | 27251789 | |
| 45 | Phosphorylation | GGSGLRASPGPGELG CCCCCCCCCCCCCCC | 24.77 | 29255136 | |
| 55 | Sumoylation | PGELGKVKKEQQDGE CCCCCCCCHHHCCCC | 54.82 | - | |
| 55 | Sumoylation | PGELGKVKKEQQDGE CCCCCCCCHHHCCCC | 54.82 | - | |
| 121 | Ubiquitination | WAQAARRKLADQYPH HHHHHHHHHHHHCCC | 42.34 | 21890473 | |
| 136 | Ubiquitination | LHNAELSKTLGKLWR CCHHHHHHHHHHHHH | 61.46 | - | |
| 140 | Ubiquitination | ELSKTLGKLWRLLNE HHHHHHHHHHHHHCC | 48.25 | 21890473 | |
| 140 | Ubiquitination | ELSKTLGKLWRLLNE HHHHHHHHHHHHHCC | 48.25 | 21890473 | |
| 140 | Acetylation | ELSKTLGKLWRLLNE HHHHHHHHHHHHHCC | 48.25 | 133803 | |
| 140 | Ubiquitination | ELSKTLGKLWRLLNE HHHHHHHHHHHHHCC | 48.25 | 21890473 | |
| 171 | Phosphorylation | HKKDHPDYKYQPRRR HCCCCCCCCCCCCCC | 18.95 | - | |
| 172 | Ubiquitination | KKDHPDYKYQPRRRK CCCCCCCCCCCCCCC | 44.80 | 21890473 | |
| 208 | Acetylation | AAIQAHYKSAHLDHR HHHHHHHHHCCCCCC | 31.16 | 20167786 | |
| 209 | Phosphorylation | AIQAHYKSAHLDHRH HHHHHHHHCCCCCCC | 17.47 | 27251275 | |
| 221 | Phosphorylation | HRHPGEGSPMSDGNP CCCCCCCCCCCCCCC | 17.09 | 29255136 | |
| 224 | Phosphorylation | PGEGSPMSDGNPEHP CCCCCCCCCCCCCCC | 45.83 | 29255136 | |
| 232 | Phosphorylation | DGNPEHPSGQSHGPP CCCCCCCCCCCCCCC | 51.91 | 29255136 | |
| 235 | Phosphorylation | PEHPSGQSHGPPTPP CCCCCCCCCCCCCCC | 33.66 | 29255136 | |
| 240 | Phosphorylation | GQSHGPPTPPTTPKT CCCCCCCCCCCCCCH | 45.06 | 29255136 | |
| 243 | Phosphorylation | HGPPTPPTTPKTELQ CCCCCCCCCCCHHHC | 57.86 | 29255136 | |
| 244 | Phosphorylation | GPPTPPTTPKTELQS CCCCCCCCCCHHHCC | 28.67 | 29255136 | |
| 246 | Sumoylation | PTPPTTPKTELQSGK CCCCCCCCHHHCCCC | 53.17 | - | |
| 246 | Sumoylation | PTPPTTPKTELQSGK CCCCCCCCHHHCCCC | 53.17 | - | |
| 247 | Phosphorylation | TPPTTPKTELQSGKA CCCCCCCHHHCCCCC | 43.03 | 25002506 | |
| 251 | Phosphorylation | TPKTELQSGKADPKR CCCHHHCCCCCCCCC | 55.69 | 25002506 | |
| 344 | Phosphorylation | PPGVALPTVSPPGVD CCCCCCCCCCCCCCC | 34.17 | 29255136 | |
| 346 | Phosphorylation | GVALPTVSPPGVDAK CCCCCCCCCCCCCCC | 28.05 | 29255136 | |
| 357 | Sumoylation | VDAKAQVKTETAGPQ CCCCEEEECCCCCCC | 28.67 | - | |
| 357 | Sumoylation | VDAKAQVKTETAGPQ CCCCEEEECCCCCCC | 28.67 | - | |
| 437 | Phosphorylation | PSQRPLYTAISDPSP CCCCCCEEECCCCCC | 25.79 | 25002506 | |
| 440 | Phosphorylation | RPLYTAISDPSPSGP CCCEEECCCCCCCCC | 40.79 | 25002506 | |
| 443 | Phosphorylation | YTAISDPSPSGPQSH EEECCCCCCCCCCCC | 36.37 | 25002506 | |
| 445 | Phosphorylation | AISDPSPSGPQSHSP ECCCCCCCCCCCCCC | 68.40 | 25002506 | |
| 449 | Phosphorylation | PSPSGPQSHSPTHWE CCCCCCCCCCCCCCC | 29.12 | 25002506 | |
| 451 | Phosphorylation | PSGPQSHSPTHWEQP CCCCCCCCCCCCCCC | 36.42 | 25002506 | |
| 453 | Phosphorylation | GPQSHSPTHWEQPVY CCCCCCCCCCCCCCE | 42.51 | 25002506 | |
| 460 | Phosphorylation | THWEQPVYTTLSRP- CCCCCCCEEECCCC- | 10.74 | 25002506 | |
| 461 | Phosphorylation | HWEQPVYTTLSRP-- CCCCCCEEECCCC-- | 22.84 | 25002506 | |
| 462 | Phosphorylation | WEQPVYTTLSRP--- CCCCCEEECCCC--- | 12.68 | 25002506 | |
| 464 | Phosphorylation | QPVYTTLSRP----- CCCEEECCCC----- | 40.18 | 25002506 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of SOX10_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of SOX10_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SOX10_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PAX3_HUMAN | PAX3 | physical | 12668617 | |
| NMI_HUMAN | NMI | physical | 16214168 | |
| FBXW7_HUMAN | FBXW7 | physical | 26461473 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 611584 | Waardenburg syndrome 2E (WS2E) | |||||
| 613266 | Waardenburg syndrome 4C (WS4C) | |||||
| 609136 | Peripheral demyelinating neuropathy, central dysmyelinating leukodystrophy, Waardenburg syndrome and Hirschsprung disease (PCWH) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-24 AND SER-45, AND MASSSPECTROMETRY. | |